InventisBio Co., Limited (SHA:688382)
China
· Delayed Price · Currency is CNY 33.90
-0.35 (-1.02%)
At close: Jun 26, 2025, 2:57 PM CST
InventisBio Market Cap
InventisBio has a market cap or net worth of 19.46 billion as of June 27, 2025. Its market cap has increased by 289.24% in one year.
Market Cap
19.46B
Enterprise Value
17.85B
Revenue
168.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
33.90
Market Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 19.46B, an increase of 121.35%. That is a compound annual growth rate of 31.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 19.46B | 153.70% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 345.13B |
| Shenzhen Mindray Bio-Medical Electronics | 275.14B |
| WuXi AppTec | 189.78B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.15B |
| Sichuan Biokin Pharmaceutical | 119.30B |
| Aier Eye Hospital Group | 115.08B |
| Shanghai United Imaging Healthcare | 105.85B |
| Yunnan Baiyao Group Co.,Ltd | 100.51B |